Start the conversation
Comment on This Story
Or to contact Money Morning Customer Service, click here.
November's already a month brimming with financial news. Last week, the Dow and the S&P hit record highs. Midterm elections saw Congress change hands, the Bank of Japan announced more economic stimulus, and Russia is close to a full-blown economic crisis.
Here at Money Morning, our experts love big news because it creates investing opportunities. They named nine of the best stocks to buy right now - and we've got them all rounded up for you right here.
Two are picks in energy, two are in the defense sector, and another two are in healthcare. Plus we've got a tech ETF, a currency ETF, and the best social media stock on the market today.
Money Morning's List of the Best Stocks to Buy Now
- Republicans crushed midterm elections Tuesday, and the news sent the stock market zooming. Both the Dow and the S&P 500 hit all-time record highs Wednesday. Money Morning Defense & Tech Specialist Michael A. Robinson told readers the GOP sweep is especially good news for tech investors. That's because he predicts three clear stock winners will come out of the policy changes Congress now has in store - one is a defense pick, one's in energy, and the third is a prominent medical device manufacturer in the healthcare sector...
- Over the last few months, we've watched pharma stock prices soar and plummet on rumors over who's got a viable Ebola vaccine in its pipeline. Robinson's not about to take part in that gamble. Instead, he pointed readers to a big-cap company with a healthy three-decade-plus track record. While this giant isn't as well-known for pharma yet, the division is actually its fastest-growing. Pharma sales increased almost 19% to $8.3 billion in Q3 alone. The company is seeking regulatory approval for at least 30 new drugsby the end of 2017. And it's gearing up for a major Ebola drug trial right now (and could have a product out in just seven months). But its progress on the Ebola front is just extra money in the pockets for investors who bet on this pharma rising star...
- On Halloween, the Bank of Japan announced it would ramp up its massive stimulus program. The news was a surprise to many; just check out these headlines: "Kuroda Surprises with Stimulus Boost" from Bloomberg, or simply "Bank of Japan Surprises Wall Street" from The Wall Street Journal. But for Money Morning Chief Investment Strategist Keith Fitz-Gerald, Japan's "surprise" stimulus was hardly that. He called this back in March 2013. That's why he was ready with three ways for investors to profit from the BoJ's move - including a currency ETF that plays on the yen's devaluation...